Trial intelligence / Profile preview

Naltrexone and CBT for Problem-Drinking MSM

NCT01115894Phase 3Unknown

Sponsor
Research Foundation for Mental Hygiene
Start
Feb 2007
Primary completion
Dec 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of naltrexone in alcohol dependence (4 arms), sponsored by Research Foundation for Mental Hygiene. Primary endpoints: Quantity of alcohol use at 9 months and Frequency of binge drinking at 9 months. Status: unknown.

02

Drugs

naltrexone
03

Conditions

alcohol dependence

Beyond the preview

Go deeper on NCT01115894.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01115894.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call